Literature DB >> 7826117

Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes.

J P Shield1, K Poyser, L Hunt, C A Pennock.   

Abstract

Fructosamine and glycated haemoglobin were measured simultaneously in 147 children with diabetes. If glycated haemoglobin is considered as the 'gold standard' for long term glycaemic control, then fructosamine is a poor indicator of actual glycated haemoglobin values, with wide 95% confidence (fiducial) limits. This shows that it is impossible to accurately predict glycated haemoglobin concentrations and therefore, by implication, longer term glycaemic control, from measurements of fructosamine. As the major studies on the prevention of microvascular complications in diabetes have used glycated haemoglobin levels to assess glycaemic control, it is suggested that this measurement should be used in all children with diabetes in preference to the measurement of fructosamine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826117      PMCID: PMC1030062          DOI: 10.1136/adc.71.5.443

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Comparisons of home blood glucose testing and glycated protein measurements.

Authors:  P D Lee; L D Sherman; M R O'Day; C L Rognerud; C N Ou
Journal:  Diabetes Res Clin Pract       Date:  1992-04       Impact factor: 5.602

2.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.

Authors:  R J Koenig; C M Peterson; R L Jones; C Saudek; M Lehrman; A Cerami
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

3.  Prevention of long term complications in diabetes.

Authors:  J P Shield; J D Baum
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

4.  Correlation of serum fructosamine activity in type I diabetic children.

Authors:  W T Cefalu; E Mejia; G R Puente; D Fleishhacker; K Macaulay
Journal:  Am J Med Sci       Date:  1989-04       Impact factor: 2.378

5.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

6.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

Authors:  J R Baker; J P O'Connor; P A Metcalf; M R Lawson; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

7.  Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.

Authors:  V J Parfitt; J D Clark; G M Turner; M Hartog
Journal:  Diabet Med       Date:  1993-03       Impact factor: 4.359

8.  Serum fructosamine and glycated haemoglobin measurements in diabetic control.

Authors:  E J Hindle; G M Rostron; S A Clark; J A Gatt
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

9.  Comparison of the real-time use of glycosylated haemoglobin and plasma fructosamine in the diabetic clinic.

Authors:  G F Watts; A F Macleod; J J Benn; B M Slavin; R W Morris; C D Williams; E M Kearney; C Lowy; P H Sönksen
Journal:  Diabet Med       Date:  1991-07       Impact factor: 4.359

  9 in total
  5 in total

1.  The protective effects of pomelo extract (Citrus grandis L. Osbeck) against fructose-mediated protein oxidation and glycation.

Authors:  Natarin Caengprasath; Sathaporn Ngamukote; Kittana Mäkynen; Sirichai Adisakwattana
Journal:  EXCLI J       Date:  2013-06-10       Impact factor: 4.068

2.  Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

3.  Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity.

Authors:  Nattha Jariyapamornkoon; Sirintorn Yibchok-anun; Sirichai Adisakwattana
Journal:  BMC Complement Altern Med       Date:  2013-07-12       Impact factor: 3.659

4.  Antidiabetic Effects of Carassius auratus Complex Formula in High Fat Diet Combined Streptozotocin-Induced Diabetic Mice.

Authors:  Zhi-Hong Wang; Cheng-Chin Hsu; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

5.  In Vitro Inhibitory Activity of Acca sellowiana Fruit Extract on End Products of Advanced Glycation.

Authors:  Alethia Muñiz; Abraham H Garcia; Rosa M Pérez; Efren V García; Daphne E González
Journal:  Diabetes Ther       Date:  2017-11-22       Impact factor: 2.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.